These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients. Schäfer U; Deuschl F; Schofer N; Frerker C; Schmidt T; Kuck KH; Kreidel F; Schirmer J; Mizote I; Reichenspurner H; Blankenberg S; Treede H; Conradi L Int J Cardiol; 2017 Apr; 232():247-254. PubMed ID: 28118931 [TBL] [Abstract][Full Text] [Related]
4. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455 [TBL] [Abstract][Full Text] [Related]
5. Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration. Vlastra W; Chandrasekhar J; Muñoz-Garcia AJ; Tchétché D; de Brito FS; Barbanti M; Kornowski R; Latib A; D'Onofrio A; Ribichini F; Baan J; Tijssen JGP; Trillo-Nouche R; Dumonteil N; Abizaid A; Sartori S; D'Errigo P; Tarantini G; Lunardi M; Orvin K; Pagnesi M; Del Valle R; Modine T; Dangas G; Mehran R; Piek JJ; Delewi R Eur Heart J; 2019 Feb; 40(5):456-465. PubMed ID: 30590565 [TBL] [Abstract][Full Text] [Related]
7. Sutureless aortic valve replacement versus transcatheter aortic valve implantation: a meta-analysis of comparative matched studies using propensity score matching. Meco M; Miceli A; Montisci A; Donatelli F; Cirri S; Ferrarini M; Lio A; Glauber M Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):202-209. PubMed ID: 29049787 [TBL] [Abstract][Full Text] [Related]
8. Propensity score matched comparison of transcatheter aortic valve implantation versus conventional surgery in intermediate and low risk aortic stenosis patients: A hint of real-world. Castrodeza J; Amat-Santos IJ; Blanco M; Cortes C; Tobar J; Martin-Morquecho I; López J; Di Stefano S; Rojas P; Varela-Falcon LH; Gomez I; San Roman JA Cardiol J; 2016; 23(5):541-551. PubMed ID: 27439368 [TBL] [Abstract][Full Text] [Related]
9. Trends over the past 4 years in population characteristics, 30-day outcomes and 1-year survival in patients treated with transcatheter aortic valve implantation. Avinée G; Durand E; Elhatimi S; Bauer F; Glinel B; Dacher JN; Cellier G; Viart G; Tron C; Godin M; Litzler PY; Cribier A; Eltchaninoff H Arch Cardiovasc Dis; 2016; 109(8-9):457-64. PubMed ID: 27342810 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Valve Durability and Outcomes of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Symptomatic Aortic Stenosis and Less-Than-High-Risk for Surgery. Tzamalis P; Alataki S; Bramlage P; Schmitt C; Schymik G Am J Cardiol; 2020 Apr; 125(8):1202-1208. PubMed ID: 32085868 [TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: A propensity-matched analysis. Villecourt A; Faroux L; Muneaux A; Tassan-Mangina S; Heroguelle V; Poncet A; Nazeyrollas P; Ruggieri VG; Metz D Arch Cardiovasc Dis; 2020 Mar; 113(3):189-198. PubMed ID: 32037133 [TBL] [Abstract][Full Text] [Related]
12. Rapid-deployment or transcatheter aortic valves in intermediate-risk patients? Bruno P; Di Cesare A; Nesta M; Cammertoni F; Mazza A; Paraggio L; Rosenhek R; Burzotta F; Crea F; Trani C; Massetti M Asian Cardiovasc Thorac Ann; 2017 May; 25(4):264-270. PubMed ID: 28361580 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry. Finkelstein A; Steinvil A; Rozenbaum Z; Halkin A; Banai S; Barbash I; Guetta V; Segev A; Danenberg H; Orvin K; Assa HV; Assali A; Kornowski R Clin Res Cardiol; 2019 Apr; 108(4):430-437. PubMed ID: 30238186 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience. Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127 [TBL] [Abstract][Full Text] [Related]
16. Evolution of Procedural and Clinical Outcomes After Balloon-Expanding Transcatheter Aortic Valve Implantation In Canada (from the Early Canadian Experience and SOURCE XT Registries). Puri R; Webb JG; Al Qoofi F; Welsh RC; Brown C; Masson JB; Natarajan MK; Peniston C; Cheema AN; Radhakrishnan S; Généreux P; Thoenes M; Côté M; Rodés-Cabau J Am J Cardiol; 2018 Aug; 122(3):461-467. PubMed ID: 29980274 [TBL] [Abstract][Full Text] [Related]
17. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort). Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962 [TBL] [Abstract][Full Text] [Related]
18. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis. Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473 [TBL] [Abstract][Full Text] [Related]
19. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience. Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967 [TBL] [Abstract][Full Text] [Related]
20. Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation. Giordano A; Corcione N; Ferraro P; Pieri P; Avellino R; Frati G; De Persio G; Altamura L; Tomai F; Biondi-Zoccai G J Cardiovasc Med (Hagerstown); 2019 May; 20(5):351-357. PubMed ID: 30676494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]